Details for New Drug Application (NDA): 200529
✉ Email this page to a colleague
The generic ingredient in INDOMETHACIN is indomethacin sodium. There are fifteen drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the indomethacin sodium profile page.
Summary for 200529
Tradename: | INDOMETHACIN |
Applicant: | Chartwell Rx |
Ingredient: | indomethacin |
Patents: | 0 |
Formulation / Manufacturing: | see details |
Medical Subject Heading (MeSH) Categories for 200529
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | CAPSULE, EXTENDED RELEASE;ORAL | Strength | 75MG | ||||
Approval Date: | Nov 30, 2010 | TE: | AB | RLD: | No |
Complete Access Available with Subscription